Altamira Therapeutics .(CYTO) - 2024 H2 - Earnings Call Transcript

Altamira Therapeutics (CYTO) H2 2024 Earnings Call April 30, 2025 08:00 AM ET Company Participants None - ExecutiveThomas Meyer - Chairman, CEO & DirectorCovadonga Pañeda - COO Operator Good day, and welcome to the Ultomira Therapeutics Full Year twenty twenty four Financial Results and Business Update Call. Today's conference is being recorded. I would now like to hand the conference over to your first speaker. Please go ahead. None Good morning, and welcome to the Ultomira Therapeutics Full Year twenty tw ...